-
Revenue
$-341.86K
Net Income
-
Gross Margin
-
Op. Margin
$-357.82K
Free Cash Flow
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Operating Expenses | - | - | - | - | - | $12.29K | $13.69K |
| Research & Development | $120.00 | $123.00K | - | - | - | - | - |
| Income Before Tax | $-2.62K | $-148.68K | $-37.44K | $-153.11K | $-44.50K | - | - |
| Net Income | $-2.62K | $-148.68K | $-37.44K | $-153.11K | $-44.50K | $-12.29K | $-13.69K |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $1.62K | $2.57K | $1.93K | $800.00 | $1.18K | $3.58K | $3.91K |
| Total Current Assets | $1.62K | $2.57K | $1.93K | $800.00 | $1.18K | $3.58K | $3.91K |
| Total Assets | $49.83K | $2.57K | $1.93K | $800.00 | $1.18K | - | $3.91K |
| Total Current Liabilities | $170.54K | $120.66K | $171.34K | $152.77K | $169.68K | $127.58K | $115.92K |
| Total Liabilities | $170.54K | $120.66K | $171.34K | $152.77K | $169.68K | - | $115.92K |
| Common Stock | $74.10K | $74.10K | $73.93K | $73.93K | $73.76K | - | $73.76K |
| Retained Earnings | $-4.75M | $-4.74M | $-4.60M | $-4.56M | $-4.41M | $-4.36M | $-4.35M |
| Total Stockholders Equity | $-120.71K | $-118.09K | $-169.41K | $-151.97K | $-168.50K | $-124.00K | $-112.02K |
| Total Liabilities & Equity | $49.83K | $2.57K | $1.93K | $800.00 | $1.18K | $3.58K | $3.91K |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Net Income | $-2.62K | $-148.68K | $-190.55K | $-153.11K | $-44.50K | $-12.29K | $-13.69K |
| Operating Cash Flow | $37.26K | $-272.22K | $-73.56K | $-49.30K | $-25.25K | $-43.72K | $-36.79K |
| Financing Cash Flow | $10.00K | $273.62K | $74.32K | $48.92K | $22.84K | $44.82K | $38.22K |
| Net Change in Cash | $-947.00 | $1.40K | $757.00 | $-375.00 | $-2.40K | $1.10K | $1.43K |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Research & Development | $123.00K | - | $123.00K | - |
| Interest Expense | - | - | - | - |
| Income Before Tax | $-148.68K | - | $-339.23K | - |
| Net Income | $-148.68K | $-13.39K | $-339.23K | - |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $2.57K | $1.18K |
| Total Current Assets | $2.57K | $1.18K |
| Total Assets | $2.57K | $1.18K |
| Total Current Liabilities | $120.66K | $169.68K |
| Total Liabilities | $120.66K | $169.68K |
| Common Stock | $74.10K | $73.76K |
| Retained Earnings | $-4.74M | $-4.41M |
| Total Stockholders Equity | $-118.09K | $-168.50K |
| Total Liabilities & Equity | $2.57K | $1.18K |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-148.68K | $-13.39K | $-339.23K | - |
| Operating Cash Flow | - | - | $-272.22K | - |
| Financing Cash Flow | - | - | $273.62K | - |
| Net Change in Cash | - | - | $1.40K | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.